Brind.

Illumina and Qiagen are noted as top players in the tumor profiling market experiencing growth in Europe.

1 report, 1 independent Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Illumina and Qiagen are noted as top players in the tumor profiling market experiencing growth in Europe.

Who's involved

What this event is mainly about
IlluminaQiagen

Keep exploring

The entities involved

  • Illumina

    American company that develops systems for the analysis of genetic variation

    Nothing else this week.

  • Qiagen

    company

    Nothing else this week.

Coverage

Newest first; wire copies grouped
  • GlobeNewswireTumor Profiling Market Growth Trends and Forecast Report 2025-2033: Tumor Profiling Market to Reach $26.56 Billion by 2033, Driven by Precision Oncology Key growth factors include rising cancer rates